^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Non Small Cell Lung Cancer
    Drug:albumin-bound paclitaxel (Tubulin inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    Source:
    NCCN
    Published date:
    03/16/2022
    Excerpt:
    Non-Small Cell Lung Cancer: Useful in Certain Circumstances…Albumin-bound paclitaxel Non-Small Cell Lung Cancer….Subsequent Systemic Therapy Option….Other Recommended: Albumin-bound paclitaxel added….PS 0-2: Albumin-bound paclitaxel added as a category 2B.